Genezen
Stop by booth 641 to meet your next viral vector partner.
Genezen is a best-in-class gene therapy CDMO with over a decade of experience focused on supporting the demands of the cell and gene therapy manufacturing market worldwide. With capabilities to work across vector-modality, Genezen partners with innovator organizations to deliver life-saving gene and cell therapies – from concept to commercial. With flexible and customer-centric programs, Genezen tailors its partnership-model approach to all sizes and stages of organizations, to make viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen’s state of the art Lexington, MA site holds multiple global regulatory licenses, including with the FDA, EMA, Health Canada, and MFDS Korea, and the company offers the following capabilities:
- Process Development
- Analytical Development
- cGMP Viral Vector Manufacturing
- Patient Sample Testing
- Cell Therapy Manufacturing
- Master Cell Bank Production and Expansion